Jakafi Interactions
There are 505 drugs known to interact with Jakafi (ruxolitinib), along with 12 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 137 are major, 307 are moderate, and 61 are minor.
- View all 505 medications that may interact with Jakafi
- View Jakafi alcohol/food interactions (2)
- View Jakafi disease interactions (12)
Most frequently checked interactions
View interaction reports for Jakafi (ruxolitinib) and the medicines listed below.
- acetaminophen
- acyclovir
- albuterol
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- azithromycin
- Bactrim (sulfamethoxazole / trimethoprim)
- doxycycline
- Eliquis (apixaban)
- furosemide
- gabapentin
- hydroxyzine
- levothyroxine
- losartan
- metformin
- metoprolol
- montelukast
- omeprazole
- ondansetron
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- tramadol
- trazodone
- valacyclovir
- Vitamin D3 (cholecalciferol)
Jakafi alcohol/food interactions
There are 2 alcohol/food interactions with Jakafi (ruxolitinib).
Jakafi disease interactions
There are 12 disease interactions with Jakafi (ruxolitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- lung toxicity
- cytopenia
- hepatic impairment
- Hepatitis B
- infections
- lipid elevations
- PML
- renal impairment
- tuberculosis
Report options
QR code containing a link to this page
More about Jakafi (ruxolitinib)
- Jakafi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (33)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
